Group One Trading
CYCN icon

Group One Trading’s Cyclerion Therapeutics CYCN Stock Holding History

Group One Trading’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$295 Hold
192
– – ﹤0.01% 7370
2025
Q4 		$244 Hold
192
– – ﹤0.01% 7873
2025
Q3 		$442 Hold
192
– – ﹤0.01% 8159
2025
Q2 		$559 Sell
192
-348
-64% -$1.04K ﹤0.01% 7643
2025
Q1 		$1.33K Hold
540
– – ﹤0.01% 7108
2024
Q4 		$1.74K Hold
540
– – ﹤0.01% 6776
2024
Q3 		$1.39K Hold
540
– – ﹤0.01% 6229
2024
Q2 		$1.23K Hold
540
– – ﹤0.01% 6326
2024
Q1 		$1.73K Hold
540
– – ﹤0.01% 6517
2023
Q4 		$1.81K Hold
540
– – ﹤0.01% 6852
2023
Q3 		$1.84K Hold
540
– – ﹤0.01% 7069
2023
Q2 		$2.22K Sell
540
-2
-0.4% -$10 ﹤0.01% 7052
2023
Q1 		$4.7K Sell
542
-25
-4% -$315 ﹤0.01% 6307
2022
Q4 		$7.44K Sell
567
-331
-37% -$3.92K ﹤0.01% 6153
2022
Q3 		$15K Sell
898
-20
-2% -$344 ﹤0.01% 6250
2022
Q2 		$10K Buy
918
+5
+0.5% +$72 ﹤0.01% 6747
2022
Q1 		$20K Sell
913
-365
-29% -$8.79K ﹤0.01% 6741
2021
Q4 		$44K Sell
1,278
-420
-25% -$19.8K ﹤0.01% 6432
2021
Q3 		$104K Buy
1,698
+1,242
+272% +$81.3K ﹤0.01% 5870
2021
Q2 		$36K Buy
456
+84
+23% +$5.26K ﹤0.01% 6823
2021
Q1 		$21K Buy
372
+315
+553% +$23.7K ﹤0.01% 6740
2020
Q4 		$4K Buy
57
+50
+714% +$3.41K ﹤0.01% 6085
2020
Q3 		$1K Sell
7
-9
-56% -$1.03K ﹤0.01% 5905
2020
Q2 		$2K Hold
16
– – ﹤0.01% 5544
2020
Q1 		$1K Buy
+16
New +$1.14K ﹤0.01% 5061

Other funds holding CYCN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Group One Trading's CYCN Position: Q1 2026 in Review

Group One Trading held its Cyclerion Therapeutics (CYCN) position steady in Q1 2026 at 192 shares worth $295. The position accounts for ﹤0.01% of the portfolio, ranked #7370.

Group One Trading first reported a position in CYCN in Q1 2020 and has held it in 25 quarters since. The position peaked at $104K in Q3 2021. 17 funds tracked by Wall St. Rank hold CYCN as of Q1 2026.

  • Group One Trading held 192 shares of Cyclerion Therapeutics worth $295 as of Q1 2026.
  • Group One Trading left its Cyclerion Therapeutics share count unchanged in Q1 2026.
  • Cyclerion Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7370 holding.
  • Group One Trading first reported a position in Cyclerion Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Group One Trading's Cyclerion Therapeutics position peaked at $104K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.